Drugs / Dendritic Cell/Tumor Fusion Vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00622401 | Dec 2009 → Oct 2014 | breast cancer | Beth Israel Deaconess Medical Center | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dendritic Cell/Tumor Fusion Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00622401 ↗ |
| Modality | Vaccine | “investigational Dendritic Cell/Tumor Fusion vaccine” NCT00622401 ↗ |
| Route | Subcutaneous | “injection of tumor cells fused with dendritic cells under the skin every 3 weeks” NCT00622401 ↗ |